The Lancet Oncology, 1470-2045

Journal

1 - 10 out of 56Page size: 10

Publications

  1. 2019
  2. Published

    Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

    Mark Drayson, Dickens Pratt & 5 others, , Peter Hawkey, Anna Whittaker, 1 Dec 2019, In : The Lancet Oncology. 20, 12, p. 1760-1772

    Research output: Contribution to journal › Article

  3. Accepted/In press

    International Standards for the Analysis of Quality of Life and Patient Reported Outcomes Endpoints in Cancer Randomised Controlled Trials: Recommendations based on critical reviews of the literature and international multi-expert, multi-stakeholder collaborative process.

    Melanie Calvert & 15 others, , 19 Nov 2019, (Accepted/In press) In : The Lancet Oncology.

    Research output: Contribution to journal › Article

  4. Published

    A European paediatric cancer mission: aspiration or reality?

    Pamela Kearns, 3 Sep 2019, In : The Lancet Oncology. 20, 9, p. 1200-1202 3 p.

    Research output: Contribution to journal › Comment/debate

  5. Published

    Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

    Rich Fox, Yuk Ting Ma, John Neoptolemos & 7 others, James Raftery, Shihua Zhu, 1 May 2019, In : The Lancet Oncology. 20, 5, p. 663-673 11 p.

    Research output: Contribution to journal › Article

  6. Published

    Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer: The Teenage and Young Adult Cancer Survivor Study – a population-based cohort study

    Raoul Reulen & Michael Hawkins, Apr 2019, In : The Lancet Oncology. 20, 4, p. 531-545 15 p.

    Research output: Contribution to journal › Article

  7. Published

    Patient-reported outcome monitoring in a routine paediatric oncology setting: challenges and opportunities

    Geetinder Kaur, Derek Kyte & Melanie Calvert, 3 Jan 2019, In : The Lancet Oncology. 20, 1, p. 19-20 2 p.

    Research output: Contribution to journal › Comment/debate

  8. Published

    Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

    Mark Drayson & 2 others, , Jan 2019, In : The Lancet Oncology. 20, 1, p. 57-73 17 p.

    Research output: Contribution to journal › Article

  9. 2018
  10. Published

    Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    Sean Kehoe, 6 Dec 2018, In : The Lancet Oncology. 19, 12, p. 1680-1687 8 p.

    Research output: Contribution to journal › Article

  11. Published

    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

    Melanie Calvert & 11 others, , 1 Sep 2018, In : The Lancet Oncology. 19, 9, p. E459-E469 11 p.

    Research output: Contribution to journal › Article

  12. Published

    Ten year Report on the European Paediatric Medicine Regulation: Impact on New Drugs for Childrens' Cancers

    Pamela Kearns, Mar 2018, In : The Lancet Oncology. 19, 3, p. 285-287 3 p.

    Research output: Contribution to journal › Comment/debate

Previous 1 2 3 4 5 6 Next